APP and pancreatic neoplasm: APP has been shown to promote proliferation of the BxPC3 pancreatic cancer cell line, conferring this activity through the soluble N-terminal fragment (24,48), and soluble APLP2 has been identified in the secretome of another pancreatic cancer cell line, SUIT-2 (49).